NeuroCatch™ Platform Receives Health Canada Medical Device Licence for Brain Function Assessment

Thursday, March 28, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Objective brain function assessment system revolutionizes the ABCs of cognitive function Soon to be available to clinicians and researchers in Canada

SURREY, BC, March 28, 2019 /CNW/ - NeuroCatch Inc. has received a Health Canada medical device licence for Canada's first and only objective, rapid neuro-physiological brain
function assessment system, through the measurement of event-related potentials (ERPs), that is easy-to-use, cost-effective, and readily accessible: the NeuroCatch™ Platform. NeuroCatch Inc. is a brain-focused health technology company committed to translating research innovations into real-world medical devices and applications.

A wholly owned subsidiary of HealthTech Connex, Inc. whose president and chief scientific officer is renowned neuroscientist Dr. Ryan D'Arcy, NeuroCatch Inc. created the NeuroCatch Platform as a scientific, evidence-based approach for the clinical utilization of ERPs, and an objective, rapid neuro-physiological brain function assessment system that is easy-to-use, cost-effective, and readily accessible to clinicians and researchers. It consists of a portable, all-in-one hardware and software system that captures electroencephalograph (EEG) data and automatically extracts critical ERP brainwave information and rapidly translates this information into an easy to use clinical report.

"NeuroCatch Inc. is proud to receive a Health Canada medical device licence for our objective brain function assessment system and bring this highly significant tool and medical resource directly to clinicians and researchers. This system is based on years of evidence-based science and research completed by our incredible team," says Kirk Fisher, CEO of NeuroCatch Inc. "Now clinicians and researchers have a readily deployable, rapid and highly accurate system that can help them make objective brain function assessments." 

With the Health Canada Class II medical device license, NeuroCatch Inc. is poised to bring the NeuroCatch Platform to brain-focused clinicians and researchers throughout Canada, the first being the Surrey Neuroplasticity Clinic at the Health and Technology District.

"We are excited to be the first in Canada to offer the NeuroCatch Platform as a brain function assessment tool for our clients," says Sonia Brodie, Clinic Enterprise Manager at the Surrey Neuroplasticity Clinic. "As a neuro-rehabilitation therapy clinic focused on clients with neurological conditions, it is extremely valuable to have such a device that our therapists can easily use to objectively and accurately measure brain function."

How the NeuroCatch Platform works:The NeuroCatch Platform consists of EEG electrodes embedded in a mesh cap, which wirelessly interface with the custom software platform. The NeuroCatch software enables the user to setup a client for a scan: an approximately 6-min proprietary audio stimulus sequence that has been specifically designed to elicit desired brain responses.

The NeuroCatch Platform provides an objective neuro-physiological assessment using three key ERPs using a standard medical ABC format: Auditory Sensation (N100]); Basic Attention (P300); and Cognitive Processing (N400). The data is then output into a NeuroCatch Platform Report, which clinicians can use to assist them in evaluating their patients.

The NeuroCatch Platform is also currently being used for investigative research in several locations across Canada and the U.S., including the Mayo Clinic, Alberta Children's Hospital Research Institute and the Bruyère Research Institute.

For more information on the NeuroCatch Platform, visit www.NeuroCatch.com.  

About the Surrey Neuroplasticity Clinic: The Surrey Neuroplasticity Clinic (SNC) is a neuro-rehabilitation clinic in Surrey, British Columbia, focusing on comprehensive therapies using advanced, non-invasive brain technologies to help treat people with neurological conditions. The clinical team consists of multidisciplinary therapists expertly trained with the latest, innovative technologies to support the brain's ability to heal, adapt, retrain and transform itself. The SNC is proud to be Western Canada's first clinic to have access to the cutting-edge PoNS Heuro Treatment. https://snpc.tech

About NeuroCatch Inc.: NeuroCatch Inc. is a neuro-health technology company focused on translating neuroscience research innovations into real-world medical devices and consumer products. Located within the Health and Technology District in Surrey, British Columbia, NeuroCatch Inc. is a wholly owned subsidiary of HealthTech Connex Inc. It's first medical device, the NeuroCatch Platform, is Canada's first and only objective, rapid neuro-physiological brain function assessment system that is easy-to-use, cost-effective and readily accessible.

The company's mission is to revolutionize the way the brain is measured by transforming groundbreaking research & development into commercial devices that can positively impact brain health around the world. www.NeuroCatch.com

SOURCE NeuroCatch Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store